Literature DB >> 24647827

Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.

Randall Logan1, Alex C Kong, Erick Axcell, Jeffrey P Krise.   

Abstract

Many weakly basic amine-containing compounds have a strong propensity to become highly concentrated in lysosomes by virtue of an ion-trapping-type mechanism; the substrates for this are referred to as lysosomotropic. We have previously shown that many lysosomotropic drugs can produce a significant expansion in the apparent volume of lysosomes, which can ultimately result in an intracellular distribution-based drug-drug interaction. In this study, we have systematically evaluated the physicochemical and structural features of weakly basic molecules that correlate with their ability to induce an expanded lysosomal volume phenotype (ELVP) in cultured human fibroblasts. By quantitatively evaluating the cellular accumulation of Lysotracker Red, a fluorescent lysosomotropic probe, the volume of the lysosomal compartment was determined. We specifically explored the influence that lysosomotropism, molecular size, and amphiphilicity had on a molecule's ability to induce an ELVP. The capacity of these molecules to intercalation into biological membranes was also evaluated using a red blood cell hemolysis assay. The present results suggest that a molecule's potency in eliciting an ELVP is influenced by lysosomotropism, amphiphilicity, and its ability to intercalate into biological membranes. Despite being highly lysosomotropic, low-molecular-weight, nonaromatic amines failed to cause an ELVP at all concentrations evaluated.
© 2014 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  cell biology; cell culture; distribution; drug interactions; log P; membrane transport; partition coefficient; pharmacokinetics; physicochemical properties; structure-activity relationship (SAR)

Mesh:

Substances:

Year:  2014        PMID: 24647827     DOI: 10.1002/jps.23949

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  An Expandable Mechanopharmaceutical Device (2): Drug Induced Granulomas Maximize the Cargo Sequestering Capacity of Macrophages in the Liver.

Authors:  Phillip Rzeczycki; Gi Sang Yoon; Rahul K Keswani; Sudha Sud; Jason Baik; Mikhail D Murashov; Ingrid L Bergin; Kathleen A Stringer; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

2.  Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery.

Authors:  André Mateus; Laurie J Gordon; Gareth J Wayne; Helena Almqvist; Hanna Axelsson; Brinton Seashore-Ludlow; Andrea Treyer; Pär Matsson; Thomas Lundbäck; Andy West; Michael M Hann; Per Artursson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-12       Impact factor: 11.205

3.  An Expandable Mechanopharmaceutical Device (1): Measuring the Cargo Capacity of Macrophages in a Living Organism.

Authors:  Phillip Rzeczycki; Tehetina Woldemichael; Andrew Willmer; Mikhail D Murashov; Jason Baik; Rahul Keswani; Gi Sang Yoon; Kathleen A Stringer; Nair Rodriguez-Hornedo; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-12       Impact factor: 4.200

4.  GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.

Authors:  Sonia Brun; Firas Bassissi; Cindy Serdjebi; Marie Novello; Jennifer Tracz; François Autelitano; Marie Guillemot; Philippe Fabre; Jérôme Courcambeck; Christelle Ansaldi; Eric Raymond; Philipe Halfon
Journal:  Invest New Drugs       Date:  2019-02-19       Impact factor: 3.850

5.  Gleevec shifts APP processing from a β-cleavage to a nonamyloidogenic cleavage.

Authors:  William J Netzer; Karima Bettayeb; Subhash C Sinha; Marc Flajolet; Paul Greengard; Victor Bustos
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

6.  Regulating Interactions Between Targeted Nanocarriers and Mononuclear Phagocyte System via an Esomeprazole-Based Preconditioning Strategy.

Authors:  Zakia Belhadj; Bing He; Jijun Fu; Hua Zhang; Xueqing Wang; Wenbing Dai; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2020-08-25

7.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

8.  Lysosomal adaptation: How cells respond to lysosomotropic compounds.

Authors:  Shuyan Lu; Tae Sung; Nianwei Lin; Robert T Abraham; Bart A Jessen
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

9.  Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.

Authors:  Cristiano Salata; Aldo Baritussio; Denis Munegato; Arianna Calistri; Huy Riem Ha; Laurent Bigler; Fabrizio Fabris; Cristina Parolin; Giorgio Palù; Ali Mirazimi
Journal:  Pathog Dis       Date:  2015-04-30       Impact factor: 3.166

10.  Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function.

Authors:  Marco Varalda; Annamaria Antona; Valentina Bettio; Konkonika Roy; Ajay Vachamaram; Vaibhav Yellenki; Alberto Massarotti; Gianluca Baldanzi; Daniela Capello
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.